Radiation-induced lung injury☆
Section snippets
Radiographic
Within a few months of RT, increases in tissue density associated with acute inflammation or late fibrosis are typically seen on either chest x-rays (CXR) or computed tomography (CT).37 The latter is more sensitive because it provides better 3-dimensional (3D) visualization of the lung. Pleural, interlobar, and pericardial effusions may also be present. These tend to be small, asymptomatic, and often resolve spontaneously. By 12 to 24 months, the majority of patients receiving moderate-high
Clinical
RT-induced lung injury has classically been divided into acute and late. Acute pneumonitis typically presents 1 to 6 months after RT, with symptoms of shortness of breath, cough, and occasionally mild fever. The radiographic findings are variable and often unrevealing. Pneumonitis usually responds well to steroids. Typically, 40 to 60 mg of prednisone every day for several weeks, followed by a several-week taper, provides relief for most patients. It is important to consider the possibility of
Functional endpoints
The lungs’ primary function is to provide oxygen to, and extract carbon dioxide from, the pulmonary circulation. This requires effective transfer of large volumes of air through the conducting airways and effective transfer of gases at the alveolar surface. These functions are quantified by the 3 components of standard pulmonary function tests. Spirometry assesses the rate of gas movement; the most commonly measured parameter is the forced expiratory volume in 1 second (FEV1). When normalized
Dosimetric predictors of RT-induced lung injury
The complex 3D dose distribution within the lung is often displayed as a 2D dose-volume histogram (DVH). A single value of merit can be extracted from the DVH (Fig 2) , eg, the percent of lung receiving ≥20 or 30 Gy (V20 or V30), the mean lung dose (MLD), or the normal tissue complication probability.70, 71, 72, 73, 74, 75, 76
Dosimetric parameters are related to the incidence of symptomatic lung injury (Table 3) .17, 20, 75, 78, 79, 80 However, pneumonitis occurs in only a minority of
Management/modifiers of lung injury
WR-2721 (amifostine) is a phosphorylated aminothiol showing cytoprotection of normal tissues with chemotherapy and RT.87 Amifostine undergoes dephosphorylation by cellular-bound alkaline phosphatase to an active metabolite, WR-1065. Cytoprotection is believed to result from elimination of free radicals produced by the interaction of ionizing RT and water molecules, as well as radicals produced by certain cytotoxic drugs.87, 88, 89 A separate amifostine metabolite, WR-33278, has also been shown
Biology of RT-induced pulmonary injury
RT-induced lung injuries are traditionally divided into early (acute, 1-6 months post-RT) pneumonitis and late (chronic, >6 mo post-RT) fibrosis. Classically, pneumonitis results from injury to type II pneumocytes, and endothelial cells manifest after an initial latent period reflecting the inherent turnover time of the affected cells.120 Histologically, there is exudation of proteinaceous material into the alveoli, desquamation of epithelial cells from the alveolar walls, alveolar edema, and
References (142)
- et al.
Early response of lung in breast cancer irradiationRadiologic density changes measured by CT and symptomatic radiation pneumonitis
Int J Radiat Oncol Biol Phys
(2002) - et al.
Technical factors associated with radiation pneumonitis after local ± regional radiation therapy for breast cancer
Int J Radiat Oncol Biol Phys
(2002) - et al.
Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients
Radiother Oncol
(1998) - et al.
Radiation pneumonitis in patients treated for breast cancer
Radiother Oncol
(1985) - et al.
Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer
Radiother Oncol
(2000) - et al.
Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy
Int J Radiat Oncol Biol Phys
(1991) - et al.
Tangential breast irradiation with or without internal mammary chain irradiationResults of a randomized trial
Radiother Oncol
(1995) - et al.
Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer
Int J Radiat Oncol Biol Phys
(1997) - et al.
Hyperfractionated accelerated radiation therapy for non-small cell lung cancerClinical phase I/II trial
Int J Radiat Oncol Biol Phys
(1997) - et al.
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
Int J Radiat Oncol Biol Phys
(1999)
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
Int J Radiat Oncol Biol Phys
Radiation pneumonitis in lung cancer patientsa retrospective study of risk factors and the long-term prognosis
Int J Radiat Oncol Biol Phys
Radiation-induced pulmonary toxicityA dose-volume histogram analysis in 201 patients with lung cancer
Int J Radiat Oncol Biol Phys
Palliative radiotherapy for inoperable carcinoma of the lungFinal report of a RTOG multi-institutional trial
Int J Radiat Oncol Biol Phys
Stage A-II B Hodgkin’s diseasemanagement and outcome of extensive thoracic involvement
Int J Radiat Oncol Biol Phys
Thoracic radiation on Hodgkin’s diseaseDisease control and long-term complications
Int J Radiat Oncol Biol Phys
Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma
Int J Radiat Oncol Biol Phys
Results of prospective study evaluating the effects of mantle irradiation on pulmonary function
Int J Radiat Oncol Biol Phys
Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma
Int J Radiat Oncol Biol Phys
Prospective study of long-term pulmonary manifestations of mantle irradiation
Int J Radiat Oncol Biol Phys
Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury
Radiother Oncol
Injury to the lung from cancer therapyClinical syndromes, measurable endpoints, and potential scoring systems
Int J Radiat Oncol Biol Phys
Regional dose response to pulmonary irradiation using a manual method
Radiother Oncol
Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer
Radiother Oncol
Radiation-induced lung damageDose-time-fractionation considerations
Radiother Oncol
The time course of radiation therapy-induced reductions in regional perfusionA prospective study with > 5 years of follow-up
Int J Radiat Oncol Biol Phys
Radiation and the lungA reevaluation of the mechanisms mediating pulmonary injury
Int J Radiat Oncol Biol Phys
Disassociation of early and late damage in mouse lung
Int J Radiat Oncol Biol Phys
The effect of patient-specific gactors on tadiation induced regional lung injury
Int J Radiat Oncol Biol Phys
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancerPreliminary results
Int J Radiat Oncol Biol Phys
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancerA phase II trial
Lung Canc
Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing
Int J Radiat Oncol Biol Phys
Effects of proton and combined proton/ photon beam radiation on pulmonary function on patients with resectable but medically inoperable non-small cell lung cancer
Chest
The effect of pulmonary function of local and loco-regional irradiation for breast cancer
Radiother Oncol
Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning
Radiother Oncol
The pathophysiologic and roentgenologic effects of chest irradiation in breast carcinoma
Int J Radiat Oncol Biol Phys
Pulmonary reaction to upper mantle radiation therapy for Hodgkin’s disease
Chest
Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin’s disease
Int J Radiat Oncol Biol Phys
Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin’s disease
Ann Oncol
Optimization of radiation therapy, IIIA method of assessing complication probability from dose-volume histograms
Int J Radiat Oncol Biol Phys
Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
Int J Radiat Oncol Biol Phys
Dosimetric predictors of radiation-induced lung injury
Int J Radiat Oncol Biol Phys
Receiver operator curves (ROC) analysis of predictors for radiation-induced symptomatic lung injury
Int J Radiat Oncol Biol Phys
Evaluation of two dose-volume histogram reduction models for the prediction of radiation pnemonitis
Radiother Oncol
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy
Int J Radiat Oncol Biol Phys
Dose volume Histogram and 3D treatment planning evaluation of patients with pneumonitis
Int J Radiat Oncol Biol Phys
Estimations of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
Int J Radiat Oncol Biol Phys
Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer
Ann Oncol
Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung
Int J Radiat Oncol Biol Phys
Effects of the modulating agent WR-2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulfate and diethyldithio-carbamate
Biochem Pharmacol
Cited by (261)
Noninvasive Quantification of Radiation-Induced Lung Injury Using a Targeted Molecular Imaging Probe
2024, International Journal of Radiation Oncology Biology PhysicsDeep inspirational breast hold (DIBH) for right breast irradiation: Improved sparing of liver and lung tissue
2024, Clinical and Translational Radiation OncologyA Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer
2024, International Journal of Radiation Oncology Biology PhysicsHemin enhances radiosensitivity of lung cancer cells through ferroptosis
2022, Experimental Cell Research
- ☆
Supported in part by NCI Grants CA69579 and CA83721 and NIH Grant 21CA83721.